05/15/2024
3:39 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/19/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/12/2024
3:15 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
5:25 PM | Lipella Pharmaceuticals (Issuer)
Yoshimura Naoki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:26 PM | Lipella Pharmaceuticals (Issuer)
Pruchnic Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:15 PM | Kim Byong (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/19/2024
5:18 PM | Cohen Daniel R (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:19 PM | Johnston Douglas (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:21 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:22 PM | Birder Lori (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
5:24 PM | Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
12:31 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
11:19 AM | Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:20 AM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
11:13 AM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/15/2024
11:15 AM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/15/2024
5:04 AM | Lipella Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2024
4:03 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
03/06/2024
4:05 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
02/08/2024
11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
02/07/2024
4:29 PM | Gruber Michele (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/28/2023
4:28 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2023
5:22 AM | Lipella Pharmaceuticals (Filer)
| Form 424B3 | |
11/14/2023
5:22 AM | Lipella Pharmaceuticals (Filer)
| Form 424B3 | |
11/14/2023
5:14 AM | Lipella Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/08/2023
11:15 PM | Lipella Pharmaceuticals (Filer)
| Form EFFECT | |
11/07/2023
4:22 PM | Lipella Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
10/25/2023
5:30 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2023
3:02 PM | Lipella Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/11/2023
6:38 AM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2023
3:05 PM | Lipella Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:54 PM | Lipella Pharmaceuticals (Issuer)
Yoshimura Naoki (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:56 PM | Chancellor Michael B (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:57 PM | Kaufman Jonathan H (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:58 PM | Lipella Pharmaceuticals (Issuer)
Pruchnic Ryan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Battleman David S. (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:01 PM | Cohen Daniel R (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:05 PM | Kaufman Jonathan H (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
06/21/2023
4:07 PM | Chancellor Michael B (Filed by)
Lipella Pharmaceuticals (Subject)
| Form SC 13D/A | |
06/21/2023
3:49 PM | Birder Lori (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad) You might have seen that Bitcoin was one of the best performing assets of 2023.
It gained 164%.
But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin.
He found something better. Click here to find out that this 8,788% cryptocurrency is. |
06/21/2023
3:52 PM | Johnston Douglas (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:53 PM | Kim Byong (Reporting)
Lipella Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2023
4:18 PM | Lipella Pharmaceuticals (Filer)
| Form S-8 POS | |
06/02/2023
3:31 PM | Lipella Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
